BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 31707214)

  • 1. Generation of human induced pluripotent stem cell lines (NIHTVBi011-A, NIHTVBi012-A, NIHTVBi013-A) from autosomal dominant Hyper IgE syndrome (AD-HIES) patients carrying STAT3 mutation.
    Jin H; Yu Z; Navarengom K; Liu Y; Dmitrieva N; Hsu AP; Schwartzbeck R; Cudrici C; Ferrante EA; Yang D; Holland SM; Freeman AF; Boehm M; Chen G
    Stem Cell Res; 2019 Dec; 41():101586. PubMed ID: 31707214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. STAT3 modulates reprogramming efficiency of human somatic cells; insights from autosomal dominant Hyper IgE syndrome caused by STAT3 mutations.
    Yu Z; Dmitrieva NI; Walts AD; Jin H; Liu Y; Ping X; Ferrante EA; Qiu L; Holland SM; Freeman AF; Chen G; Boehm M
    Biol Open; 2020 Sep; 9(9):. PubMed ID: 32580970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diminished allergic disease in patients with STAT3 mutations reveals a role for STAT3 signaling in mast cell degranulation.
    Siegel AM; Stone KD; Cruse G; Lawrence MG; Olivera A; Jung MY; Barber JS; Freeman AF; Holland SM; O'Brien M; Jones N; Nelson CG; Wisch LB; Kong HH; Desai A; Farber O; Gilfillan AM; Rivera J; Milner JD
    J Allergy Clin Immunol; 2013 Dec; 132(6):1388-96. PubMed ID: 24184145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Manifestations and Genetic Analysis of 17 Patients with Autosomal Dominant Hyper-IgE Syndrome in Mainland China: New Reports and a Literature Review.
    Wu J; Chen J; Tian ZQ; Zhang H; Gong RL; Chen TX; Hong L
    J Clin Immunol; 2017 Feb; 37(2):166-179. PubMed ID: 28197791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hyper-IgE syndrome with mutation in STAT3 gene - case report and literature review].
    Heropolitańska-Pliszka E; Pietrucha B; Mikołuć B; Bernatowska E
    Med Wieku Rozwoj; 2009; 13(1):19-25. PubMed ID: 19648655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Potential and Limits of Hematopoietic Stem Cell Transplantation for the Treatment of Autosomal Dominant Hyper-IgE Syndrome.
    Yanagimachi M; Ohya T; Yokosuka T; Kajiwara R; Tanaka F; Goto H; Takashima T; Morio T; Yokota S
    J Clin Immunol; 2016 Jul; 36(5):511-6. PubMed ID: 27091139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A deep intronic splice mutation of
    Khourieh J; Rao G; Habib T; Avery DT; Lefèvre-Utile A; Chandesris MO; Belkadi A; Chrabieh M; Alwaseem H; Grandin V; Sarrot-Reynauld F; Sénéchal A; Lortholary O; Kong XF; Boisson-Dupuis S; Picard C; Puel A; Béziat V; Zhang Q; Abel L; Molina H; Marr N; Tangye SG; Casanova JL; Boisson B
    Proc Natl Acad Sci U S A; 2019 Aug; 116(33):16463-16472. PubMed ID: 31346092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hyper-IgE syndromes].
    He YY; Liu B; Xiao XP
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jun; 31(11):892-896. PubMed ID: 29775011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful haploidentical donor hematopoietic stem cell transplant and restoration of STAT3 function in an adolescent with autosomal dominant hyper-IgE syndrome.
    Patel NC; Gallagher JL; Torgerson TR; Gilman AL
    J Clin Immunol; 2015 Jul; 35(5):479-85. PubMed ID: 25962528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defects along the T(H)17 differentiation pathway underlie genetically distinct forms of the hyper IgE syndrome.
    Al Khatib S; Keles S; Garcia-Lloret M; Karakoc-Aydiner E; Reisli I; Artac H; Camcioglu Y; Cokugras H; Somer A; Kutukculer N; Yilmaz M; Ikinciogullari A; Yegin O; Yüksek M; Genel F; Kucukosmanoglu E; Baki A; Bahceciler NN; Rambhatla A; Nickerson DW; McGhee S; Barlan IB; Chatila T
    J Allergy Clin Immunol; 2009 Aug; 124(2):342-8, 348.e1-5. PubMed ID: 19577286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyper-IgE syndrome update.
    Sowerwine KJ; Holland SM; Freeman AF
    Ann N Y Acad Sci; 2012 Feb; 1250():25-32. PubMed ID: 22268731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the Role of
    Moffitt K; Cheung E; Manis J; Malley R
    Infect Immun; 2018 May; 86(5):. PubMed ID: 29463618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paucity of genotype-phenotype correlations in STAT3 mutation positive Hyper IgE Syndrome (HIES).
    Heimall J; Davis J; Shaw PA; Hsu AP; Gu W; Welch P; Holland SM; Freeman AF
    Clin Immunol; 2011 Apr; 139(1):75-84. PubMed ID: 21288777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. STAT3 mutation-associated airway epithelial defects in Job syndrome.
    Zhang Y; Lin T; Leung HM; Zhang C; Wilson-Mifsud B; Feldman MB; Puel A; Lanternier F; Couderc LJ; Danion F; Catherinot E; Salvator H; Tcherkian C; Givel C; Xu J; Tearney GJ; Vyas JM; Li H; Hurley BP; Mou H
    J Allergy Clin Immunol; 2023 Aug; 152(2):538-550. PubMed ID: 36638921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rescue of STAT3 Function in Hyper-IgE Syndrome Using Adenine Base Editing.
    Eberherr AC; Maaske A; Wolf C; Giesert F; Berutti R; Rusha E; Pertek A; Kastlmeier MT; Voss C; Plummer M; Sayed A; Graf E; Effner R; Volz T; Drukker M; Strom TM; Meitinger T; Stoeger T; Buyx AM; Hagl B; Renner ED
    CRISPR J; 2021 Apr; 4(2):178-190. PubMed ID: 33876960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An update on the hyper-IgE syndromes.
    Yong PF; Freeman AF; Engelhardt KR; Holland S; Puck JM; Grimbacher B
    Arthritis Res Ther; 2012 Nov; 14(6):228. PubMed ID: 23210525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Signal transducer and activator of transcription 3 (STAT3) mutations underlying autosomal dominant hyper-IgE syndrome impair human CD8(+) T-cell memory formation and function.
    Ives ML; Ma CS; Palendira U; Chan A; Bustamante J; Boisson-Dupuis S; Arkwright PD; Engelhard D; Averbuch D; Magdorf K; Roesler J; Peake J; Wong M; Adelstein S; Choo S; Smart JM; French MA; Fulcher DA; Cook MC; Picard C; Durandy A; Tsumura M; Kobayashi M; Uzel G; Casanova JL; Tangye SG; Deenick EK
    J Allergy Clin Immunol; 2013 Aug; 132(2):400-11.e9. PubMed ID: 23830147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atopic dermatitis, STAT3- and DOCK8-hyper-IgE syndromes differ in IgE-based sensitization pattern.
    Boos AC; Hagl B; Schlesinger A; Halm BE; Ballenberger N; Pinarci M; Heinz V; Kreilinger D; Spielberger BD; Schimke-Marques LF; Sawalle-Belohradsky J; Belohradsky BH; Przybilla B; Schaub B; Wollenberg A; Renner ED
    Allergy; 2014 Jul; 69(7):943-53. PubMed ID: 24898675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenesis of hyper IgE syndrome.
    Heimall J; Freeman A; Holland SM
    Clin Rev Allergy Immunol; 2010 Feb; 38(1):32-8. PubMed ID: 19452285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein stabilization improves STAT3 function in autosomal dominant hyper-IgE syndrome.
    Bocchini CE; Nahmod K; Katsonis P; Kim S; Kasembeli MM; Freeman A; Lichtarge O; Makedonas G; Tweardy DJ
    Blood; 2016 Dec; 128(26):3061-3072. PubMed ID: 27799162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.